-
Global Proto Oncogene Market & Clinical Pipeline Insight 2024: 19 Drugs Commercially Available in the Market and 166 are in Clinical Pipeline in Various Developmental Phases
26 Feb 2018 11:17 GMT
… Key market players are Dexa Medica, Eisai Pharmaceuticals, Exelixis, Pfizer, Novartis, … Targets for Treatment
Market Analysis of Proto Oncogene Therapeutic Drugs
Dosage … Tafinlar)
10.8 Vandetanib (Caprelsa, Zactima & Zictifa)
10.9 Vemurafenib …
-
The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
02 Aug 2022 00:04 GMT
… clinical trials of anlotinib in the treatment of SCLC … of Air Force Military Medical University, Xianyang Central Hospital … clinical trial with sunitinib as second-line treatment in … oxygen consumption after treatment with vandetanib (ZACTIMA; ZD6474) and …
-
Global Market for Thyroid cancer is poised to reach USD 544.24 million by 2021.
18 Aug 2017 14:54 GMT
… Zactima, XL184 and, Zybrestat have been granted orphan drug status by the FDA … radiotherapy, chemotherapy, Thyroxin treatment, Drugs. Further Chemotherapy is … pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co., Teva parenteral medicines …
-
The Secret of Successful Asia-Pacific Thyroid cancer Market 2016-2021.
14 Aug 2017 15:35 GMT
…
• External radiotherapy
• Thyroxine treatment
• chemotherapy
• Drugs
• Y-o-Y Growth … Zactima and Zybrestat have been granted orphan drug status by the FDA. … Inc., Mylan pharmaceuticals Inc., Alara Pharmaceutical Corporation, Teva parenteral medicines Inc., …
-
North America Thyroid cancer Market size Growth Factors Revealed.
03 Aug 2017 13:03 GMT
…
• External radiotherapy
• Thyroxine treatment
• chemotherapy
• Drugs
• Y-o-Y Growth … , Zactima and Zybrestat have been granted orphan drug status by the FDA. … Teva parenteral medicines Inc., App pharmaceuticals LLC and Jerome Stevens Pharmaceuticals Inc.
…
-
North America Thyroid cancer Market is projected to reach USD 220.93 million by 2021
25 Jul 2017 19:16 GMT
…
• External radiotherapy
• Thyroxine treatment
• chemotherapy
• Drugs
• Y-o-Y Growth … , Zactima and Zybrestat have been granted orphan drug status by the FDA. … Teva parenteral medicines Inc., App pharmaceuticals LLC and Jerome Stevens Pharmaceuticals Inc.
…
-
Asia-Pacific Thyroid cancer Market - Key Trends and Opportunities to 2021
24 Jul 2017 21:32 GMT
…
• External radiotherapy
• Thyroxine treatment
• chemotherapy
• Drugs
• Y-o-Y Growth … Zactima and Zybrestat have been granted orphan drug status by the FDA. … Inc., Mylan pharmaceuticals Inc., Alara Pharmaceutical Corporation, Teva parenteral medicines Inc., …